arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Corvus Pharmaceuticals, Inc.

CRVS Health Care Biotechnology: Pharmaceutical Preparations
$11.12
▼ -5.1% Today
as of Jun 7, 07:12 ET
Last 30 days -28.81% Apr 28 → Jun 05
$10.73 $12.15 $13.57 $14.99 $16.41 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$11.67
High
$11.99
Low
$11.04
Volume
$1M
Avg Vol
$2M
Mkt Cap
$1.1B
P/E (TTM)
Beta
52w High
$26.95
52w Low
$3.55
Div Yield
Shares Out
$84M

Overview

52-week range
$3.55
$27
32% of range
Avg surprise (last 2)
-3.6%
Avg reaction (last 2)
-0.4%
50% positive
Latest IV / EM
81%
EM ±11.2% · $11 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.60$-0.47$-0.33$-0.20$-0.07 Actual $-0.14Actual $-0.12Actual $-0.12Actual $-0.07Actual $-0.60Actual $-0.13Est $-0.13Actual $-0.10Actual $-0.12Actual $-0.15Est $-0.14 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-40M$-26M$-12M$2M$16M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $-0.15 $-0.14 -7.1% -15.4% -5.6% earnings
Tue Sep 30, 2025Sep 2025 $-0.12 financials
Mon Jun 30, 2025Jun 2025 $-0.10 financials
Thu May 8, 2025Mar/2025 $-0.13 $-0.13 0.0% +4.7% earnings
Mon Sep 30, 2024Sep 2024 $-0.60 financials
Sun Jun 30, 2024Jun 2024 $-0.07 financials
Sun Mar 31, 2024Mar 2024 $-0.12 financials
Sat Sep 30, 2023Sep 2023 $-0.12 financials
Fri Jun 30, 2023Jun 2023 $-0.14 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-15M$-11M$-10M$-10M$-7M$-6M
Net income$-14M$-10M$-8M$15M$-40M$-4M
EPS (diluted)$-0.15$-0.12$-0.10$-0.13$-0.60$-0.07

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$40M$5M$3M$15M$5M$9M$5M$15M
Inventory
Total current assets$240M$58M$67M$76M$45M$54M$43M$48M
Total assets$253M$71M$80M$89M$59M$69M$59M$65M
Long-term debt
Total liabilities$13M$10M$9M$9M$10M$36M$46M$13M
Total equity$241M$61M$72M$80M$49M$33M$12M$51M

Implied volatility — last 90 days

76%78%81%83%86% Jun 07 — IV 81% · EM ±11.2%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.